Analytical Data
-
Gene name
MAEA
- Application
-
Alternative Names
EMP; HLC10; PIG5; Cell proliferation-inducing gene 5 protein; Erythroblast macrophage protein; Human lung cancer oncogene 10 protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7L5Y9
-
Expression Region
Cys136~Pro379
-
Molecular Weight
29kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MAEA (Male Abdominal-Emerging Antigen) is a protein of significant interest in the field of molecular biology and immunology due to its potential role in male reproductive health and various pathophysiological conditions. Research on MAEA has been increasingly focused on understanding its structure, function, and interactions at the cellular level. Its expression is linked to spermatogenesis and male fertility, suggesting that alterations in MAEA expression could have implications for understanding infertility and other reproductive disorders. Furthermore, investigations into MAEA's role in tumor biology have revealed its possible involvement in cancer pathogenesis. The recombination of MAEA aids in producing a purified form of the protein, facilitating studies on its biochemical properties and its interactions with other cellular molecules. This restructured version of MAEA enables researchers to explore its therapeutic potential and application in diagnostics, particularly in male-associated conditions and cancers. As ongoing studies advance, incorporating advanced techniques such as CRISPR and proteomics, the comprehensive understanding of MAEA may lead to novel insights and approaches for treating various diseases linked to its functionality. Through these efforts, MAEA emerges as a crucial target for future research, contributing to the broader field of reproductive health and cancer therapeutics.
